BioSpace News Archive

Deborah Heart and Lung Center is celebrating its 100th anniversary, marking the Hospital’s founding in 1922, and subsequent incorporation the following year.

Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a late-stage biopharmaceutical company developing and commercializing first-in-class critical care products, today announced that it will present at the H.C. Wainwright Global Investment Conference being held May 23-26, 2022.

Humanetics Corporation has added two additional clinical sites to its long-haul COVID-19 study, which is focused on patients who were treated for severe COVID-19 and face the possible risk that their respiratory complications will lead to long-term impairment of lung function.

G1 Therapeutics, Inc., a commercial-stage oncology company, announced that Jack Bailey, G1’s Chief Executive Officer, will provide a virtual corporate presentation during the H.C. Wainwright & Co. Global Investment Conference.

The Foundation for Sarcoidosis Research, the leading international nonprofit organization dedicated to finding a cure and improving care for sarcoidosis patients, is pleased to announce the American Thoracic Society /Foundation for Sarcoidosis Research Grant awardee, Auyon Ghosh MD, MPH, for his proposal “Gene expression signatures of extrapulmonary sarcoidosis.”

Athos Therapeutics, Inc., a late-stage preclinical biotech company using artificial intelligence to develop small molecule therapeutics for immune-mediated diseases and cancer, announced that Abraham Verghese, MD, MACP has been named to the Company’s Board of Directors.

Cala Health, the bioelectronic medicine leader setting a new standard of patient care for chronic disease, today announced new clinical research presented at ISPOR 2022.

Neurogene Inc., a company founded on the vision to push the boundaries of genetic medicine to address complex and devastating neurological diseases, announced the addition of NGN-401 for Rett syndrome to the Company’s development pipeline.

Amanda M. Simanek, PhD, MPH, has been named founding director of the Michael Reese Research and Education Foundation Center for Health Equity Research at Rosalind Franklin University.

Prenetics Group Limited, a global leader in genomic and diagnostic testing, and Artisan Acquisition Corp., a special purpose acquisition company privately founded by renowned cultural entrepreneur Adrian Cheng, completed their previously announced business combination.